A detailed history of Advisor Partners Ii, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 82,528 shares of ABBV stock, worth $14.6 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
82,528
Previous 79,225 4.17%
Holding current value
$14.6 Million
Previous $10.7 Million 15.25%
% of portfolio
0.5%
Previous 0.5%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $441,247 - $510,808
3,303 Added 4.17%
82,528 $12.3 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $86,131 - $107,185
-650 Reduced 0.81%
79,225 $10.7 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $555,447 - $639,680
3,841 Added 5.05%
79,875 $12.7 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.2 Million - $1.44 Million
8,655 Added 12.85%
76,034 $12.3 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $9.04 Million - $10.4 Million
67,379 New
67,379 $9.04 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.